Jonathan M. Loree

6.9k total citations · 3 hit papers
177 papers, 3.7k citations indexed

About

Jonathan M. Loree is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Jonathan M. Loree has authored 177 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Oncology, 59 papers in Cancer Research and 50 papers in Pathology and Forensic Medicine. Recurrent topics in Jonathan M. Loree's work include Colorectal Cancer Treatments and Studies (75 papers), Cancer Genomics and Diagnostics (56 papers) and Genetic factors in colorectal cancer (47 papers). Jonathan M. Loree is often cited by papers focused on Colorectal Cancer Treatments and Studies (75 papers), Cancer Genomics and Diagnostics (56 papers) and Genetic factors in colorectal cancer (47 papers). Jonathan M. Loree collaborates with scholars based in Canada, United States and Australia. Jonathan M. Loree's co-authors include Scott Kopetz, Michael J. Overman, Kanwal Raghav, Arvind Dasari, Igor Koturbash, Kristy Kutanzi, Olga Kovalchuk, Aparna R. Parikh, Igor P. Pogribny and David G. Menter and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jonathan M. Loree

155 papers receiving 3.6k citations

Hit Papers

Disparity of Race Reporting and Representation in Clinica... 2019 2026 2021 2023 2019 2022 2024 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018
    2019 365 citations Jonathan M. Loree, Seerat Anand et al. JAMA Oncology profile →
  2. Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices
    2022 161 citations Midhun Malla, Jonathan M. Loree et al. Journal of Clinical Oncology profile →
  3. Management of Locally Advanced Rectal Cancer: ASCO Guideline
    2024 47 citations Lisa A. Kachnic, Hagen F. Kennecke et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan M. Loree Canada 31 2.2k 966 921 877 745 177 3.7k
Kanwal Raghav United States 33 2.9k 1.3× 1.2k 1.2× 1.1k 1.2× 1.2k 1.4× 628 0.8× 203 4.3k
Claudia Allemani United Kingdom 28 2.3k 1.0× 801 0.8× 521 0.6× 731 0.8× 515 0.7× 84 4.3k
Blasé N. Polite United States 32 3.3k 1.5× 822 0.9× 654 0.7× 1.1k 1.3× 733 1.0× 164 4.9k
Séamus O’Reilly Ireland 35 3.9k 1.8× 1.6k 1.7× 756 0.8× 1.2k 1.4× 1.4k 1.9× 227 6.8k
Monika Klinkhammer‐Schalke Germany 27 1.4k 0.6× 372 0.4× 607 0.7× 552 0.6× 567 0.8× 171 2.9k
Angeles Alvarez Secord United States 46 2.3k 1.0× 580 0.6× 675 0.7× 738 0.8× 1.5k 1.9× 288 7.2k
Gianpiero Fasola Italy 29 2.0k 0.9× 377 0.4× 625 0.7× 1.3k 1.4× 598 0.8× 175 3.2k
Scott Berry Canada 19 2.3k 1.0× 413 0.4× 391 0.4× 1.1k 1.2× 442 0.6× 72 3.2k
Victor R. Grann United States 37 2.7k 1.2× 934 1.0× 1.0k 1.1× 759 0.9× 336 0.5× 66 5.0k
Bhawna Sirohi India 33 1.7k 0.8× 431 0.4× 514 0.6× 792 0.9× 817 1.1× 171 3.8k

Countries citing papers authored by Jonathan M. Loree

Since Specialization
Citations

This map shows the geographic impact of Jonathan M. Loree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Loree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Loree more than expected).

Fields of papers citing papers by Jonathan M. Loree

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Loree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Loree. The network helps show where Jonathan M. Loree may publish in the future.

Co-authorship network of co-authors of Jonathan M. Loree

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan M. Loree. A scholar is included among the top collaborators of Jonathan M. Loree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan M. Loree. Jonathan M. Loree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kennecke, Hagen F., Christopher J. O’Callaghan, Dongsheng Tu, et al.. (2024). The NEO-RT trial: A phase 3 randomized trial of neoadjuvant chemotherapy, excision and observation versus chemoradiotherapy for early rectal cancer, CCTG CO.32.. Journal of Clinical Oncology. 42(16_suppl). TPS3646–TPS3646. 1 indexed citations
2.
Carter, Michael D., Shaan Dudani, Jonathan M. Loree, et al.. (2024). Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. SHILAP Revista de lepidopterología. 5(1). 1–10. 4 indexed citations
3.
Titmuss, Emma, Robert J. Vanner, David F. Schaeffer, et al.. (2024). Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors. Cancer Research Communications. 5(1). 66–73. 2 indexed citations
4.
Titmuss, Emma, Dongsheng Tu, Stephanie Yasmin Brule, et al.. (2024). Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials. Clinical Cancer Research. 30(6). 1121–1130. 3 indexed citations
5.
Ruan, Yibing, Jennifer J. Telford, Mary A. De Vera, et al.. (2023). Association of Reducing the Recommended Colorectal Cancer Screening Age With Cancer Incidence, Mortality, and Costs in Canada Using OncoSim. JAMA Oncology. 9(10). 1432–1432. 14 indexed citations
6.
Gibbs, Peter, et al.. (2023). Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer—A Clinical Vignette Study. Cancers. 15(21). 5227–5227. 2 indexed citations
7.
Malla, Midhun, Jonathan M. Loree, Pashtoon Murtaza Kasi, & Aparna R. Parikh. (2022). Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices. Journal of Clinical Oncology. 40(24). 2846–2857. 161 indexed citations breakdown →
8.
Kennecke, Hagen F., Chris J. O’Callaghan, Jonathan M. Loree, et al.. (2022). Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results. Journal of Clinical Oncology. 41(2). 233–242. 31 indexed citations
9.
Raghav, Kanwal, Hyunsoo Hwang, Alexandre A. Jácome, et al.. (2021). Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary. Clinical Cancer Research. 27(12). 3414–3421. 26 indexed citations
10.
Lu, Na, Alison M. Hoens, Jacek A. Kopec, et al.. (2021). Immunosuppression and COVID-19 infection in British Columbia: Protocol for a linkage study of population-based administrative and self-reported survey data. PLoS ONE. 16(11). e0259601–e0259601. 2 indexed citations
11.
Sarshekeh, Amir Mehrvarz, Jason Roszik, Ganiraju C. Manyam, et al.. (2021). ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 27(6). 1663–1670. 40 indexed citations
12.
Howren, Alyssa, Eric C. Sayre, Jonathan M. Loree, et al.. (2021). Trends in the Incidence of Young-Onset Colorectal Cancer With a Focus on Years Approaching Screening Age: A Population-Based Longitudinal Study. JNCI Journal of the National Cancer Institute. 113(7). 863–868. 27 indexed citations
13.
Loree, Jonathan M., Dongsheng Tu, Derek J. Jonker, et al.. (2020). Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial. Clinical Cancer Research. 27(1). 52–59. 19 indexed citations
14.
Unger, Joseph M., Dawn L. Hershman, Raymond U. Osarogiagbon, et al.. (2020). Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies. JNCI Cancer Spectrum. 4(4). pkaa034–pkaa034. 75 indexed citations
15.
Chu, Jenny E., Benny Johnson, Van K. Morris, et al.. (2020). Population-based Screening for BRAF V600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis. Clinical Cancer Research. 26(17). 4599–4605. 31 indexed citations
16.
Lee, Michael K.C. & Jonathan M. Loree. (2019). Current and Emerging Biomarkers in Metastatic Colorectal Cancer. Current Oncology. 26(11). 7–15. 36 indexed citations
17.
Advani, Shailesh, Stacia M. DeSantis, Derek W. Brown, et al.. (2018). Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis. Translational Oncology. 11(5). 1188–1201. 43 indexed citations
18.
Strickler, John H., Jonathan M. Loree, Leanne G. Ahronian, et al.. (2017). Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer. Cancer Discovery. 8(2). 164–173. 196 indexed citations
19.
Loree, Jonathan M., Allan Andresson Lima Pereira, Michael Lam, et al.. (2017). Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes. Clinical Cancer Research. 24(5). 1062–1072. 201 indexed citations
20.
Thierry, Alain R., Brice Pastor, Zhi-Qin Jiang, et al.. (2017). Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer. Clinical Cancer Research. 23(16). 4578–4591. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kanwal Raghav Breakdown of academic impact, for papers by Claudia Allemani Breakdown of academic impact, for papers by Blasé N. Polite Breakdown of academic impact, for papers by Séamus O’Reilly Breakdown of academic impact, for papers by Monika Klinkhammer‐Schalke Breakdown of academic impact, for papers by Angeles Alvarez Secord Breakdown of academic impact, for papers by Gianpiero Fasola Breakdown of academic impact, for papers by Scott Berry Breakdown of academic impact, for papers by Victor R. Grann Breakdown of academic impact, for papers by Bhawna Sirohi
Rankless by CCL
2026